Therapeutic Transformation for Patients with Diabetes and CKD
RPA Annual Meeting
SGLT2 inhibitors represent a major advance in the treatment of patients with chronic kidney disease due to their ability to slow progression of CKD and delay the need for dialysis. They also have been shown to have cardio-protective effects.
Kidney & Diabetes
Tuttle, Katherine, "Therapeutic Transformation for Patients with Diabetes and CKD" (2021). Articles, Abstracts, and Reports. 4696.